PK/PD Evaluation Resistance Development in Caseating Granuloma
PK/PD Evaluation Resistance Development in Caseating Granuloma
批准号:
7668649
负责人:
WILLIAM Ramses BISHAI
金额:
$63.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-07 至 2012-07-31
关键词:
AddressAdjuvant TherapyAnimal ModelAnimalsAnti-Inflammatory AgentsAnti-inflammatoryAntibioticsAutopsyBacteriaCaviaClarithromycinDevelopmentDexamethasoneDoseDrug CombinationsDrug LabelingDrug resistanceDrug usageEtanerceptEvaluationFiberFrequenciesGranulomaHigh Pressure Liquid ChromatographyImageImaging technologyImmunosuppressive AgentsIn SituIn VitroInflammationLabelLeadLesionLifeLungMicrobeModelingMusMycobacterium tuberculosisNecrosisOryctolagus cuniculusPathologicPatientsPenetrationPharmaceutical PreparationsPharmacodynamicsPhotonsPositronPositron-Emission TomographyPropertyRecombinantsRelative (related person)ResistanceResistance developmentRoleSamplingSerumSiteSteroidsSystemTestingThymidine KinaseTissuesTuberculosisX-Ray Computed Tomographybacterial resistancebasefialuridineinhibitor/antagonistnoveltooltuberculosis treatment
中文摘要
描述(由申请人提供):活动性结核病导致肺空洞,结核菌在肺空洞中生长到高水平。空洞性结核病更容易传染给他人,患者更难治疗,更有可能导致耐药性。该提议将联合收割机与新型放射成像技术和传统药理学工具结合,以确定结核腔是否作为细菌可能逃避高药物浓度并产生耐药性的避难所。这项研究的最后一部分将确定是否给予免疫抑制药物,阻止腔发展与抗生素一起是有用的,在加速治愈结核病的动物模型。
英文摘要
DESCRIPTION (provided by applicant): Active tuberculosis causes lung cavities where TB-bacteria grow to high levels. Cavitary TB is more transmissible to others, harder to treat in the patient who has it, and more likely to lead to drug resistance. This proposal will combine an animal model in which TB cavities reproducibly develop with novel radiologic imaging technologies and traditional pharmacologic tools to determine whether the TB cavity serves as a sanctuary site where bacteria may escape high drug concentrations and develop resistance. The last part of the study will determine whether giving immunosuppressive drugs which block cavity development together with antibiotics is useful in accelerating cure in an animal model of TB.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic and hormonal mechanisms mediating sex differences in TB and TB-HIV
-
批准号:10557906
-
项目类别:
-
资助金额:$81.38万
-
财政年份:2022
-
负责人:WILLIAM Ramses BISHAI
-
依托单位:
Genetic and hormonal mechanisms mediating sex differences in TB and TB-HIV
-
批准号:10484064
-
项目类别:
-
资助金额:$81.38万
-
财政年份:2022
-
负责人:WILLIAM Ramses BISHAI
-
依托单位:
Microbiology, Immunology, Animal Modeling and Imaging
-
批准号:10431023
-
项目类别:
-
资助金额:$13.92万
-
财政年份:2022
-
负责人:WILLIAM Ramses BISHAI
-
依托单位:
Microbiology, Immunology, Animal Modeling and Imaging
-
批准号:10593152
-
项目类别:
-
资助金额:$14.07万
-
财政年份:2022
-
负责人:WILLIAM Ramses BISHAI
-
依托单位:
A STINGing vaccine for TB
-
批准号:10415895
-
项目类别:
-
资助金额:$105.14万
-
财政年份:2020
-
负责人:WILLIAM Ramses BISHAI
-
依托单位:
Treg-depleting immunotherapy
-
批准号:10370465
-
项目类别:
-
资助金额:$118.86万
-
财政年份:2020
-
负责人:WILLIAM Ramses BISHAI
-
依托单位:
Targeted cell-depleting immunotherapy for TB and HIV
-
批准号:10556322
-
项目类别:
-
资助金额:$67.28万
-
财政年份:2020
-
负责人:WILLIAM Ramses BISHAI
-
依托单位:
Glutamine metabolism inhibitors for TB and TB-HIV: dual action as host-directed therapies with antibacterial activity
-
批准号:10686328
-
项目类别:
-
资助金额:$81.38万
-
财政年份:2020
-
负责人:WILLIAM Ramses BISHAI
-
依托单位:
Targeted cell-depleting immunotherapy for TB and HIV
-
批准号:10012368
-
项目类别:
-
资助金额:$67.28万
-
财政年份:2020
-
负责人:WILLIAM Ramses BISHAI
-
依托单位:
Glutamine metabolism inhibitors for TB and TB-HIV: dual action as host-directed therapies with antibacterial activity
-
批准号:10456845
-
项目类别:
-
资助金额:$81.38万
-
财政年份:2020
-
负责人:WILLIAM Ramses BISHAI
-
依托单位:
Treg-depleting immunotherapy
-
批准号:10376845
-
项目类别:
-
资助金额:$81.14万
-
财政年份:2020
-
负责人:WILLIAM Ramses BISHAI
-
依托单位:
Glutamine metabolism inhibitors for TB and TB-HIV: dual action as host-directed therapies with antibacterial activity
-
批准号:10160564
-
项目类别:
-
资助金额:$78.02万
-
财政年份:2020
-
负责人:WILLIAM Ramses BISHAI
-
依托单位:
Targeted cell-depleting immunotherapy for TB and HIV
-
批准号:10320031
-
项目类别:
-
资助金额:$67.28万
-
财政年份:2020
-
负责人:WILLIAM Ramses BISHAI
-
依托单位:
Glutamine metabolism inhibitors for TB and TB-HIV: dual action as host-directed therapies with antibacterial activity
-
批准号:10264948
-
项目类别:
-
资助金额:$81.38万
-
财政年份:2020
-
负责人:WILLIAM Ramses BISHAI
-
依托单位:
Targeted cell-depleting immunotherapy for TB and HIV
-
批准号:10113540
-
项目类别:
-
资助金额:$67.28万
-
财政年份:2020
-
负责人:WILLIAM Ramses BISHAI
-
依托单位:
A STINGing vaccine for TB
-
批准号:10622623
-
项目类别:
-
资助金额:$116.15万
-
财政年份:2020
-
负责人:WILLIAM Ramses BISHAI
-
依托单位:
A STINGing vaccine for TB
-
批准号:10085403
-
项目类别:
-
资助金额:$84.24万
-
财政年份:2020
-
负责人:WILLIAM Ramses BISHAI
-
依托单位:
A STINGing vaccine for TB
-
批准号:10171783
-
项目类别:
-
资助金额:$80.89万
-
财政年份:2020
-
负责人:WILLIAM Ramses BISHAI
-
依托单位:
Targeted Immunotherapy for Tuberculosis and HIV co-infection
-
批准号:9296756
-
项目类别:
-
资助金额:$24.49万
-
财政年份:2017
-
负责人:WILLIAM Ramses BISHAI
-
依托单位:
Aberrant immune activation in the tuberculosis granuloma: a pivotal role in necrosis
-
批准号:9316705
-
项目类别:
-
资助金额:$73.74万
-
财政年份:2016
-
负责人:WILLIAM Ramses BISHAI
-
依托单位:
海外基金